Clinical Study of Mitoxantrone Hydrochloride Liposome Injection Combined With Capecitabine Versus Capecitabine Monotherapy in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma Who Failed Platinum-containing Treatment
Clinical trial NCT05717764 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05717764
- Sponsor
- CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-01
- Primary completion
- 2026-09-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.